Theratechnologies Inc T.TH

Th1902-

[palinc2000]

Still very much alive it seems

[SPCEO1]

Yes, but it seems like it is a 2024 story as the objective of getting to cash flow positive this year probably negates any significant spending on TH-1902 this year. Hopefully, the new effort to target healthier patients and tumors where TH-1902 has already shown activity with smaller, more frequent doses will be accepted by the FDA and will work. 

[Wino115]

Yep. Depends on whether they budgeted something in the $28mil RD line Dubuc mentioned. I can't imagine the water RD and IM would cost all that. Certainly can't do a 40-50 person trial, but perhaps you find the 2-3 cancers you want to ramp and do a much smaller 10 each test, get 20-30 more responses at $150-200k each and see if the theories work. It is just a question of timing and it could

[qwerty22]

I think you are right to say there is no rush to restart oncology. With that in mind there's probably also no rush to go public on the path forward. I don't think what Christian is saying today is pinpointing the problem. It's broad possibilities. If you know you aren't starting soon then why not take all the time to dive into the problem and find the answers. Why at this early